← Go back

Date of filling in this questionnaire or last update: 26/05/2020
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  CAOUvid
Country
 

  • Italy
Name
  Sara De Matteis
Institution
  University of Cagliari
Email
  sara.dem@unica.it
Name of committee
  local ethics committe of AUO Policlinico Universitario “D.Casula” di Monserrato, Cagliari, Italy
Contact Principal Investigator (name)
  Sara De Matteis
Data access policy (briefly describe)
  email request to PI
Is this cohort part of a consortium? (name consortium)
  not yet
Participation in pooled analyses
 

  • The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).
Main aim of cohort, please briefly describe the main objectives of the cohort
  the overall goal is to assess incidence and prevalence of infection to SARS-CoV-2 and consequent COVID-19 in relation to several individual, occupational and environmental risk factors
Study design (please select as many as appropriate)
 

  • Prospective cohort
Source population (please select as many as appropriate)
 

  • Industry / occupation-based
Comparators (please select as many as appropriate)
 

  • Internal study population
  • External comparison of workers with other exposure
  • External study population (includes SMR/SIR studies)
Inclusion criteria
  current employee of AUO Policlinico Universitario “D.Casula” di Monserrato, Cagliari, Italy and consent to participate in the study
Enrollment
  Completed
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Active (contact with participants)
  • Death certificate
  • Disease incidence records
  • Hospital / physician diagnoses
Active (contact with participants) (specify)
 

  • online questionnaire and clinical assessment including nasopharyngeal swab to test covid-19
Death certificate (specify)
 

  • for assessment covid-19-related death
Disease incidence records (specify)
 

  • for reference general population
Hospital / Physician diagnoses (specify)
 

  • for covid-19 diagnosis
First follow-up period (provide year)
  2020
Comments
  open prospective cohort of hospital healthcare workers
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Questionnaire, Personal (Self-reporting or interview)
  • Questionnaire, Personal (Occupational/industry modules)
Occupational history/time frame
  Current, at enrollment
Occupational coding performed
  No
Types of exposure measurements
 

  • Biomarkers (see also section 5)
  • Personal external sampling
Methods for exposure assessment (please select as many as appropriate)
 

  • Measurements (external sampling, biomarkers)
  • Self-report
Main categories
 

  • Biological factors
Biological factors | Bacteria
 

  • Mycobacterium tuberculosis
Biological factors | Viruses
 

  • Hepatitis (Hep B, Hep C, etc.)
  • HIV
  • Influenza (all types)
  • Other (specify)
Biological factors | Viruses | Specify: Other
  sars-cov-2
Comments
  nasopharyngeal swabs to test for sarscov2 and test for other respiratory virus and bloodborn virus
4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Biomarker (specify)
  • Clinical/functional evaluation, e.g. spirometry, ECGs (specify)
  • Death certificates
  • Medical records
  • Questionnaire, individual (self-recording or interview)
Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Biomarker (specify)
  • Clinical/functional evaluation, e.g. spirometry, ECGs (specify)
  • Medical records
  • Questionnaire, individual (self-recording or interview)
Outcome type (please select as many as appropriate)
 

  • Mortality
  • Morbidity
  • Disability
Diagnostic groups based on ICD10
 

  • B Viral infections, type of microorganisms*
  • E Metabolism disease
  • F Mental disorders
  • H Disorders of the eye
  • I Heart disease
  • J Respiratory disease
B Viral infections, type of microorganisms
 

  • SARS coronavirus
5. BIOLOGICAL SAMPLES & ANALYSIS
Biological samples collected
 

  • Blood
  • Other
Specify: Other
  nasopharyngeal swabs and blood tests
Biological processing
 

  • DNA
  • RNA
Genetic and other lab analyses
 

  • Biomarkers (specify)
6. Other Information
 

  • Anthropometry
  • Demographics
  • Education
  • Medical history
  • Socioeconomic status
  • Smoking